Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Need responsive customer support
The FDA has approved specific GLP-1 medications for type 2 diabetes management and, in higher doses, certain agents (semaglutide 2.4 mg, liraglutide 3 mg, tirzepatide) for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity
The American Academy of Pediatrics emphasizes that very few drugs are absolute contraindications, and each situation should be evaluated individually
The clinical trial study is slated to run until November of 2027
TrimRx provides accessible GLP-1 therapy through licensed providers, offering both compounded semaglutide at $199/month and compounded tirzepatide at $349/month with complete medical support
US$ 20.20
US$ 22.66
US$ 27.30
US$ 20.93
US$ 24.21
US$ 28.32
